Literature DB >> 7110243

Kinetics and distribution of 111Indium-labeled platelets in patients with homocystinuria.

R L Hill-Zobel, R E Pyeritz, U Scheffel, O Malpica, S Engin, E E Camargo, M Abbott, T R Guilarte, J Hill, P A McIntyre, E A Murphy, M F Tsan.   

Abstract

Homocystinuria is an inborn error of metabolism involving a high incidence of thromboembolism. It sometimes improves with large doses of pyridoxine. We investigated the kinetics and distribution of 111Indoxine-labeled platelets in 11 normal volunteers and 12 patients with homocystinuria, none of whom had clinical evidence of acute thrombosis at the time of the study. Six of the patients were resistant to pyridoxine and had homocystinemia. There were no statistical differences in mean platelet-survival times between pyridoxine responders and nonresponders or between normal subjects and pyridoxine responders or nonresponders, regardless of whether a linear, exponential, or multiple-hit model was used to analyze the kinetic data. Plasma homocystine levels had no apparent effect on mean platelet-survival time. There was no abnormal accumulation of platelets in any of the patients, and the distribution of platelets in liver and spleen was similar to that in normal subjects. Our results suggest that the kinetics and distribution of platelets in patients with homocystinuria who have no clinical evidence of thromboembolism are normal. Thus, the data do not provide evidence for disordered platelet function or for an ongoing interaction of platelets with vessel walls in this condition.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7110243     DOI: 10.1056/NEJM198209233071303

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  7 in total

1.  Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.

Authors:  G M Rodgers; W H Kane
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

2.  111In-tropolonate labelled platelets; studies in normals and in patients with thrombocytopenia.

Authors:  H Louwes; H Beekhuis; W T Goedemans; S P Keijser; J J Schuurman
Journal:  Eur J Nucl Med       Date:  1987

3.  Functional alterations of human platelets following indium-111 labelling using different incubation media and labelling agents.

Authors:  Y Isaka; K Kimura; M Matsumoto; T Kamada; M Imaizumi
Journal:  Eur J Nucl Med       Date:  1991

4.  Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor.

Authors:  K A Hajjar
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

5.  Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen.

Authors:  J S Stamler; J A Osborne; O Jaraki; L E Rabbani; M Mullins; D Singel; J Loscalzo
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

6.  The natural history of homocystinuria due to cystathionine beta-synthase deficiency.

Authors:  S H Mudd; F Skovby; H L Levy; K D Pettigrew; B Wilcken; R E Pyeritz; G Andria; G H Boers; I L Bromberg; R Cerone
Journal:  Am J Hum Genet       Date:  1985-01       Impact factor: 11.025

7.  Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism.

Authors:  G Di Minno; G Davì; M Margaglione; F Cirillo; E Grandone; G Ciabattoni; I Catalano; P Strisciuglio; G Andria; C Patrono
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.